FibroBiologics Doses First Participant In Its Phase 1/2 Clinical Study Of CYWC628 To Treat Diabetic Foot Ulcers
Fibrobiologics Inc FBLG
$0.77
▼ -3.73%
($-0.03)
Open
$0.82
Prev Close
$0.80
Day Range
$0.77 – $0.83
52W Range
$0.77 – $15.55
Market Cap
$4.01M
Beta
-0.80
EPS (TTM)
$-5.21
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-01-31 |
| Shares Out. | 5,210,000 |
| Website | fibrobiologics.com/ ↗ |
| Phone | 12816715150 |
Fibrobiologics Inc is a publicly traded company under the ticker symbol FBLG on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-06-01)